Weiguo Wan

735 total citations
28 papers, 568 citations indexed

About

Weiguo Wan is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Weiguo Wan has authored 28 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Weiguo Wan's work include Tissue Engineering and Regenerative Medicine (6 papers), Cardiac Ischemia and Reperfusion (6 papers) and Electrospun Nanofibers in Biomedical Applications (5 papers). Weiguo Wan is often cited by papers focused on Tissue Engineering and Regenerative Medicine (6 papers), Cardiac Ischemia and Reperfusion (6 papers) and Electrospun Nanofibers in Biomedical Applications (5 papers). Weiguo Wan collaborates with scholars based in China and United States. Weiguo Wan's co-authors include Cui Zhang, Tianxin Ye, Xuejun Jiang, Bo Yang, Congxin Huang, Xin Yi, Xin Liu, Bo Yang, Cui Zhang and Bin Zeng and has published in prestigious journals such as Journal of the American College of Cardiology, Biochemical and Biophysical Research Communications and Pharmacology & Therapeutics.

In The Last Decade

Weiguo Wan

28 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiguo Wan China 15 212 174 94 67 51 28 568
Chengpeng Li China 13 182 0.9× 107 0.6× 109 1.2× 61 0.9× 37 0.7× 59 693
Tingbo Jiang China 13 259 1.2× 199 1.1× 128 1.4× 47 0.7× 109 2.1× 61 698
Huiliang Qiu United States 13 142 0.7× 163 0.9× 71 0.8× 53 0.8× 30 0.6× 24 444
Gustavo Monnerat Brazil 14 316 1.5× 257 1.5× 113 1.2× 45 0.7× 38 0.7× 34 675
Monia Savi Italy 16 271 1.3× 154 0.9× 121 1.3× 50 0.7× 52 1.0× 37 710
Leonardo Bocchi Italy 14 305 1.4× 202 1.2× 121 1.3× 42 0.6× 51 1.0× 23 709
Shinichiro Takashima Japan 15 226 1.1× 254 1.5× 117 1.2× 20 0.3× 45 0.9× 55 633
Parmeshwar B. Katare India 12 240 1.1× 79 0.5× 36 0.4× 62 0.9× 45 0.9× 19 529
Hiroko Fujii Japan 13 244 1.2× 102 0.6× 163 1.7× 55 0.8× 30 0.6× 26 697

Countries citing papers authored by Weiguo Wan

Since Specialization
Citations

This map shows the geographic impact of Weiguo Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiguo Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiguo Wan more than expected).

Fields of papers citing papers by Weiguo Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiguo Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiguo Wan. The network helps show where Weiguo Wan may publish in the future.

Co-authorship network of co-authors of Weiguo Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Weiguo Wan. A scholar is included among the top collaborators of Weiguo Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiguo Wan. Weiguo Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiaoli, et al.. (2022). Pinocembrin alleviates the susceptibility to atrial fibrillation in isoproterenol-induced rats. Biochemical and Biophysical Research Communications. 636(Pt 1). 33–40. 5 indexed citations
2.
Ran, Qian, Cui Zhang, Weiguo Wan, et al.. (2022). Pinocembrin ameliorates atrial fibrillation susceptibility in rats with anxiety disorder induced by empty bottle stimulation. Frontiers in Pharmacology. 13. 1004888–1004888. 6 indexed citations
3.
Chen, Xiaoli, Weiguo Wan, Qian Ran, et al.. (2022). Pinocembrin mediates antiarrhythmic effects in rats with isoproterenol-induced cardiac remodeling. European Journal of Pharmacology. 920. 174799–174799. 21 indexed citations
4.
Jiang, Xuejun, Qunhui Wang, Zhe Qu, et al.. (2022). Data-independent acquisition proteomics reveals circulating biomarkers of coronary chronic total occlusion in humans. Frontiers in Cardiovascular Medicine. 9. 960105–960105. 2 indexed citations
5.
Ran, Qian, Xiaoli Chen, Cui Zhang, et al.. (2022). Pinocembrin Decreases Atrial Fibrillation Susceptibility in a Rodent Model of Depression. Frontiers in Cardiovascular Medicine. 9. 766477–766477. 6 indexed citations
6.
Wan, Weiguo, Tianxin Ye, Xiaoli Chen, et al.. (2021). Pinocembrin alleviates lipopolysaccharide-induced myocardial injury and cardiac dysfunction in rats by inhibiting p38/JNK MAPK pathway. Life Sciences. 277. 119418–119418. 28 indexed citations
7.
Wan, Weiguo, Yan Guo, Tianxin Ye, et al.. (2021). Pinocembrin ameliorates post-infarct heart failure through activation of Nrf2/HO-1 signaling pathway. Molecular Medicine. 27(1). 100–100. 41 indexed citations
8.
Ye, Tianxin, Cui Zhang, Gang Wu, et al.. (2020). Pinocembrin Decreases Ventricular Fibrillation Susceptibility in a Rat Model of Depression. Frontiers in Pharmacology. 11. 547966–547966. 20 indexed citations
9.
Wen, Ying, et al.. (2020). Clinical characteristics and antibiotics treatment in suspected bacterial infection patients with COVID-19. International Immunopharmacology. 90. 107157–107157. 31 indexed citations
10.
Ye, Tianxin, Cui Zhang, Gang Wu, et al.. (2019). Pinocembrin attenuates autonomic dysfunction and atrial fibrillation susceptibility via inhibition of the NF-κB/TNF-α pathway in a rat model of myocardial infarction. International Immunopharmacology. 77. 105926–105926. 42 indexed citations
11.
Zhu, Hongling, Xiaoyan Li, Mingjie Yuan, et al.. (2017). Intramyocardial delivery of bFGF with a biodegradable and thermosensitive hydrogel improves angiogenesis and cardio-protection in infarcted myocardium. Experimental and Therapeutic Medicine. 14(4). 3609–3615. 24 indexed citations
12.
Wan, Weiguo, et al.. (2017). The versatility and paradox of GDF 11. Pharmacology & Therapeutics. 175. 28–34. 32 indexed citations
13.
Wan, Weiguo, Vahagn Ohanyan, Molly Enrick, et al.. (2017). Alignment of inducible vascular progenitor cells on a micro-bundle scaffold improves cardiac repair following myocardial infarction. Basic Research in Cardiology. 112(4). 41–41. 11 indexed citations
15.
Otali, Dennis, Robert J. Novak, Weiguo Wan, et al.. (2014). Increased production of mitochondrial reactive oxygen species and reduced adult life span in an insecticide-resistant strain ofAnopheles gambiae. Bulletin of Entomological Research. 104(3). 323–333. 23 indexed citations
17.
Zhao, Mouming, et al.. (2014). Effects of the ginkgo biloba extract on the superoxide dismutase activity and apoptosis of endothelial progenitor cells from diabetic peripheral blood. Genetics and Molecular Research. 13(1). 220–227. 13 indexed citations
18.
Yi, Xin, et al.. (2014). Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of cardiac fibroblasts. International Journal of Molecular Medicine. 34(2). 381–390. 48 indexed citations
19.
Wan, Weiguo, Xuejun Jiang, Xiaoyan Li, Cui Zhang, & Xin Yi. (2013). Silencing of angiotensin-converting enzyme by RNA interference prevents H9c2 cardiomyocytes from apoptosis induced by anoxia/reoxygenation through regulation of the intracellular renin-angiotensin system. International Journal of Molecular Medicine. 32(6). 1380–1386. 9 indexed citations
20.
Huang, Congxin, Jinjun Liang, Bo Yang, et al.. (2006). Quality of Life and Cost for Patients with Premature Ventricular Contractions by Radiofrequency Catheter Ablation. Pacing and Clinical Electrophysiology. 29(4). 343–350. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026